ARCH PHARMALABS LIMITED
Public Limited Indian Non-Government CompanyUnlistedACTIVE compliantCIN: U24231MH1993PLC150891
INDICATIVE PRICE₹ —Last allotment: 29 Dec 2023
UA Score75/100
CIN
Incorp. Date02 Apr 1993
Paid-up Capital₹156.48 Cr
Open Charges₹5668.24 Cr
Last AGM29 Dec 2023
PAN
Company Summary
Arch Pharmalabs Limited (APL), as per its credit rating report, is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates, and also provides contract…
PharmaAPI ManufacturersContract Research
Incorporation02 Apr 1993
Age33+ years
PANAACCM0306Q
StatusUnlisted
LocationMumbai, Maharashtra
IndustryPharma
🎙️ Company Audio Brief
1-Minute Company Overview
Listen to key insights • 1:00 min
💡 Quick Investor Summary
🏢
What They Do
Arch Pharmalabs Limited (APL), as per its credit rating report, is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs) and pharma...
📈
Financial Health
Reporting More than 1000 cr. in revenue. Currently operating at a more than 5 cr..
🛡️
Positive Aspects
Maintains active compliance with regulators.
⚠️
Key Risk
Payment delays in EPF (true). Significant registered debt charges open.
Key Highlights
ℹRevenue: More than 1000 cr.
✓Profit: More than 5 cr.
⚠Bureau defaults on record
⚠Pending legal cases filed
⚠GST filing delay: true
⚠EPF payment delay: true
ℹEmployees: Upto 100
Management Team
RP
RAJENDRAKUMAR PADMANABHAN KAIMAL
Whole-time directorDIN: 00032839Since 01 Nov 2018
AA
AJIT ANNU KAMATH
Managing DirectorDIN: 00032799Since 01 Nov 2018
SM
SUNIL MANSUKHLAL PITRODA
DirectorDIN: 07028212Since 29 Dec 2018
Show 18 past directors
SJ
SHAILESH JAYANTILAL MEHTA
DirectorDIN: 01633893Ceased 30 Mar 2013
AR
ALURI RAO SRINIVASA
Nominee DirectorDIN: 00147058Ceased 08 Apr 2008
PD
PRAMOD DEVADAS SHEDDE
Nominee DirectorDIN: 00310025Ceased 19 Dec 2007
MT
MANOJ TEJRAJ JAIN
DirectorDIN: 00034727Ceased 27 Apr 2016
JK
JAYANTA KUMAR BANERJEE
Nominee DirectorDIN: 00151010Ceased 27 May 2010
HS
HIRA SADHAK
DirectorDIN: 00203098Ceased 01 Apr 2013
SK
SRINIVAS KOPPISETTY
Nominee DirectorDIN: 00514607Ceased 09 Dec 2010
AD
ABHISHEK DEEPAK BUDDHADEV
Additional DirectorDIN: 07673161Ceased 01 Apr 2017
SD
SHANTILAL DALICHAND JAIN
DirectorDIN: 00053142Ceased 15 Mar 2013
MR
MALLIKARJUNA REDDY TIRUMALAREDDY
Whole-time directorDIN: 00298545Ceased 30 May 2016
SV
SUNIL VASANT DIWAKAR
Nominee DirectorDIN: 00089266Ceased 09 Dec 2010
VR
VANDANA RAJADHYAKSHA
Nominee DirectorDIN: 00164120Ceased 16 Jan 2013
SS
SHAHZAAD SIRAJ DALAL
Nominee DirectorDIN: 00011375Ceased 28 Jan 2008
RM
RAMAKANT MADHAV NAYAK
DirectorDIN: 00129854Ceased 01 Apr 2013
PB
PALAK BIPIN SHAH
Additional DirectorDIN: 03392059Ceased 14 Jun 2018
RS
RAJIV SARMAN SHUKLA
Nominee DirectorDIN: 02143904Ceased 30 Nov 2009
PV
PUTHENVEETIL VINCENT JOHN
DirectorDIN: 00096857Ceased 01 Apr 2013
LK
LOKESH KUMAR
Nominee DirectorDIN: 02576600Ceased 28 Nov 2014
IPO Pipeline
IPO Tracker
Financial Data
Financial Statements
📊 Showing 1 year of data. Upgrade to Premium for full 5-year history.
Total Employees
Upto 100
CSR Expenditure
Not Specified
Profit & Loss Statement
| Line Item | FY 2023 |
|---|---|
| Net Revenue | ₹1340.98 Cr |
| Total Operating Cost | ₹66.90 Cr |
| Operating Profit / (Loss) | ₹179.75 Cr |
| Other Income | ₹3.17 Cr |
| Depreciation | ₹23.48 Cr |
| Profit Before Tax | ₹124.69 Cr |
| Income Tax | ₹0 |
| Profit After Tax (PAT) | ₹124.69 Cr |
Balance Sheet
| Line Item | FY 2023 |
|---|---|
| ASSETS | |
| Non-Current Investments | ₹42.43 Cr |
| Net Fixed Assets | ₹812.13 Cr |
| Total Non-Current Assets | ₹82.01 Cr |
| Cash & Bank Balances | ₹2.69 Cr |
| Trade Receivables | ₹632.20 Cr |
| Total Current Assets | ₹1443.37 Cr |
| Total Assets | ₹2367.44 Cr |
| LIABILITIES & EQUITY | |
| Share Capital | ₹156.48 Cr |
| Reserves & Surplus | ₹664.62 Cr |
| Total Equity | ₹821.11 Cr |
| Long-Term Borrowings | ₹641.88 Cr |
| Deferred Tax (Net) | — |
| Total Non-Current Liabilities | ₹654.58 Cr |
| Short-Term Borrowings | ₹162.57 Cr |
| Trade Payables | ₹226.15 Cr |
| Total Current Liabilities | ₹891.75 Cr |
| Total Debt | ₹804.45 Cr |
Cash Flow Statement
| Line Item | FY 2023 |
|---|---|
| Operating Cash Flow | ₹45.95 Cr |
| Investing Cash Flow | -₹1.39 Cr |
| Financing Cash Flow | -₹44.56 Cr |
| Net Change in Cash | ₹35,000 |
| Closing Cash Balance | ₹2.69 Cr |
Analytics
Charts & Ratios
Insufficient data to compute Enterprise Value to EBITDA. CMP or reliable EBITDA metrics missing.
OCF vs PAT Ratio
Revenue & Profit Trend
Key Ratios
Debt & Equity
Cash Flow Breakdown
Key Ratios Table
Regulatory & Legal
Governance & Compliance
Ownership Structure
Capitalization Table
Industry Benchmarking
Peer Comparison
No peer comparison data available for this company.
Market Sentiments
Latest News
Recent News
No recent news found or analyzed for this company.
MCA Filings